Some patients with locally advanced rectal cancer may be able to safely forgo radiation before surgery to remove tumors, according to research published June 4 in The New England Journal of Medicine and the Journal of Clinical Oncology.
The Latest
Grail, a company that developed blood tests to detect cancer, mistakenly sent approximately 400 customers letters saying they might be positive for the disease, The New York Times reported June 4.
GenesisCare, a global cancer and cardiac care service provider, has filed for Chapter 11 bankruptcy, according to a June 1 press release.
Here are the 10 most-read oncology stories published by Becker's in May:
Some immunotherapies and small molecule kinase inhibitors have been shown to cause "major fungal infections," according to a study led by a researcher from Nutley, N.J.-based Hackensack Meridian Center for Discovery and Innovation.
Some immunotherapies and small molecule kinase inhibitors have been shown to cause "major fungal infections," according to a study led by a researcher from Nutley, N.J.-based Hackensack Meridian Center for Discovery and Innovation.
Screenings that were delayed due to COVID-19 are likely to contribute to an exponential increase in cancer diagnosis totals over the next few years, experts say.
Some critics are speaking out against the U.S. Preventive Services Task Force's recommendation to lower the mammogram screening age to 40, KFF Health News reported May 30.
A study led by researchers from Hadassah-University Medical Center in Jerusalem found a 90 percent success rate in treating multiple myeloma and putting patients into remission, the Jerusalem Post reported May 29.
Some oncologists are rationing cancer drugs and delaying patient treatment as the shortages grow worse, NBC News reported May 28.